Group 1 - Paulig has sold its Risenta brand to Midsona for Skr45 million ($4.7 million) as part of its strategy to focus on world foods and Tex Mex [1][2] - The sale includes Risenta's brand, intellectual property, associated business, and production lines, but does not involve transferring any staff to Midsona [2][3] - Midsona views the acquisition as a way to strengthen its position in the healthy foods market in Sweden, expecting the deal to increase its EBIT margin and earnings per share, while adding around Skr130 million in annual revenue [3] Group 2 - Paulig has been reshaping its manufacturing footprint, including plans to end production at a spices plant in Mölndal and shift operations to Estonia due to higher input costs [4] - The company announced a €12 million ($14.1 million) investment to expand capacity at its Berga facility in Barcelona, including a new flour tortilla line to meet growing global demand for Tex-Mex products [4]

Core Viewpoint - James Hardie expands its strategic agreement with CBUSA, enhancing access to preferred products for custom builders [1] Group 1: Company Overview - James Hardie is a leader in exterior design solutions in North America [1] - The company has a long-standing relationship with CBUSA, the largest group purchasing organization for custom home builders in the U.S. [1] Group 2: Agreement Details - The new three-year exclusive deal will benefit CBUSA's network of nearly 1,000 custom builders [1] - Builders will gain access to preferred products, including TimberTech®, the top brand in premium composite and PVC decking and railing solutions [1]

Core Viewpoint - Jefferies downgraded Rockwell Automation from Buy to Hold, reducing the price target from $490 to $380 due to concerns over AI disintermediation impacting future growth potential [2][4]. Company Performance - Rockwell Automation is currently trading at approximately $348.51, reflecting a year-to-date loss of nearly 13% and significantly below its 52-week high of $438.72 [3]. - In Q1 FY2026, Rockwell reported an EPS of $2.75, exceeding the consensus estimate of $2.48, with revenue of $2.105 billion, representing an 11.8% year-over-year growth [7]. - The Software & Control segment, closely linked to AI developments, saw its operating margin increase to 31.2% from 25.1% in the previous year, with organic growth of 17% [7]. Valuation Concerns - Jefferies highlighted that Rockwell's current P/E ratio stands at 39.8 and a PEG ratio of 4.53, indicating limited room for error if growth slows or competitive dynamics change [6]. - The firm expressed that the valuation is already reflecting Rockwell's strong position in reshoring and onshoring, suggesting that the positive narrative is priced into the stock [5]. Future Outlook - The company has provided FY2026 organic sales growth guidance of 2%-6%, with a midpoint of 4%, which Jefferies considers insufficient to justify the current valuation multiple [7]. - The Lifecycle Services segment reported a decline in organic growth of -6% in Q1, and free cash flow decreased by 41.98% year-over-year [7]. Market Sentiment - Despite the downgrade, the broader analyst community remains positive, with a consensus target price of $431.37 based on 30 ratings, including 11 Buy and 14 Hold recommendations [8]. - The stock has decreased by 15.44% over the past month, indicating that the market is already grappling with the implications of AI disruption on Rockwell's business model [9].

Fund Performance - Platinum International Technology Fund achieved a 3% return in Q4 2025 and a 13.1% return for the entire year, outperforming the benchmark returns of 2.5% and 12.4% respectively [1] - The depreciation of the U.S. Dollar negatively impacted both the Fund and Benchmark returns when measured in Australian dollars [1] Market Environment - The market was characterized as 'risk-on', with defensive sectors such as Real Estate and Consumer Staples underperforming, while discretionary consumer businesses showed mixed results [1] - For 2026, the firm anticipates a similar investment environment as in 2025 and 2024, aiming to avoid extreme events [1] Company Focus - Jacobs Solutions Inc. (NYSE:J) is highlighted as a key stock, providing infrastructure and advanced facilities, with a market capitalization of $14.74 billion [2] - The stock of Jacobs Solutions Inc. experienced a one-month return of -10.14% and a 52-week gain of 3.37% [2] Investment Outlook - Jacobs Solutions Inc., along with Microsoft and Uber, detracted from the Fund's quarterly returns by between 0.5% and 0.8% each, but the company is viewed positively for the long term [3] - The engineering services industry is facing potential disruption from AI, but Jacobs Solutions is expected to be a net beneficiary of the AI revolution, with management actively investing in AI to enhance efficiencies [4][5]

Market Overview - Major indices are experiencing a rally, with the Dow up 455 points (approximately 1%), the Nasdaq up 187 points (almost 1%), and the S&P up 59 points (almost 1%) [1] - Wall Street is concluding its worst quarter in four years, with major indices down 7 to 8% over the last three months [1] - Oil prices have surged over 50% since the onset of the war on February 28th [1] Oil Prices and Economic Impact - Current trading prices for Brent oil are at $115.58, up 2.5%, and crude oil at $104.14, up 1.3% [2] - The Gulf region's economic significance is highlighted, with jet fuel prices in Asia having more than doubled [7] - A prolonged period of elevated oil prices could lead to significant global economic issues, particularly if it extends beyond a few weeks [8] Economic Analysis - Historical analysis indicates that it takes multiple factors to push a diversified economy into recession, with oil price spikes being one of many potential contributors [5][11] - The likelihood of an energy-related recession in the U.S. is estimated at 10% in any given year, based on historical data [10] - Central banks' responses to inflationary pressures from energy price shocks can exacerbate economic contractions [15][16] Investment Strategy - Maintaining a diversified investment portfolio tailored to individual risk profiles is recommended as a prudent strategy during economic fluctuations [19] - Historical lessons suggest that while recessions cannot be avoided, poor policy decisions can worsen their impact [20][21]

Core Viewpoint - Suncor Energy has announced a new 3-year improvement plan, increasing its annual share repurchases by over 20% to a revised projection of $4 billion for 2026 [1]. Group 1: Investor Day Highlights - The Investor Day presentation is available for live webcast and future viewing on Suncor's website [2]. - Suncor has filed a report disclosing its contingent resources, accessible on various platforms including SEDAR and SEC [2]. Group 2: Company Overview - Suncor Energy is recognized as Canada's leading integrated energy company, with operations covering the entire energy value chain, including oil sands mining, upgrading, offshore production, and petroleum refining [3]. - The company emphasizes safety, operational excellence, and profitability, aiming to deliver industry-leading performance and long-term shareholder value [3]. Group 3: Financial Projections and Goals - Suncor projects a $2 billion increase in normalized free funds flow by 2028 [8]. - The company aims for a US$5 per barrel reduction in corporate WTI breakeven to US$38 per barrel by 2028 [8]. - An increase of 100,000 barrels per day in upstream production is targeted by 2028 [8]. - Suncor plans a 10% increase in refining network nameplate capacity to 511,000 barrels per day [8]. - The company anticipates an 11 billion barrel increase in contingent resources, totaling 30 billion barrels with no exploration risk [8]. - Future production capacity is projected at 400,000 barrels per day, with an average cost of $30,000 per flowing barrel [8].

Core Insights - AerSale Corporation has announced the lease of a Boeing 757-200 Precision Converted Freighter (PCF) to Stratos Freight, an all-cargo airline based in Tashkent, Uzbekistan, enhancing its operational capabilities in the logistics market [1][4]. Company Overview - AerSale is a leading global provider of aviation aftermarket products and services, focusing on integrated solutions for aircraft owners and operators, including MRO services, aircraft and engine sales, and leasing [5]. - Stratos Freight specializes in high-efficiency airfreight services, operating along key trade routes connecting China, the Middle East, and Europe [6]. Strategic Positioning - Stratos Freight is strategically located at the intersection of Asia and Europe, which allows it to operate effectively along major logistics routes [2][6]. - The addition of the Boeing 757-200PCF to Stratos Freight's fleet is expected to enhance its scheduled and charter cargo operations throughout Central Asia and beyond [2]. Aircraft Capabilities - The Boeing 757-200PCF is recognized for its versatility, efficiency, and suitability for regional cargo operations, making it an ideal choice for express and regional missions [3]. - The aircraft's deployment is anticipated to improve connectivity across high-demand trade lanes, emphasizing the importance of efficiency and reliability in cargo operations [3]. Business Model - AerSale's integrated business model leverages its expertise in aircraft leasing, freighter conversions, and asset management to provide value-driven solutions to airline partners globally [4].

Core Insights - Alpha Tau Medical Ltd. has announced that an abstract detailing results from two clinical trials on its alpha-radiation cancer therapy, Alpha DaRT, for pancreatic cancer has been accepted for oral presentation at Digestive Disease Week (DDW) 2026, marking a significant recognition of its technology in a major gastroenterology conference [1][2][3] Company Overview - Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company founded in 2016, focusing on the research, development, and potential commercialization of Alpha DaRT for treating solid tumors [5] - The Alpha DaRT technology was initially developed by Professors Itzhak Kelson and Yona Keisari from Tel Aviv University [5] Technology Details - Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed for highly potent and conformal alpha-irradiation of solid tumors through intratumoral delivery of radium-224 sources, aiming to primarily affect the tumor while sparing surrounding healthy tissue [6] Clinical Trial Presentation - The abstract titled "Updated Results of Feasibility, Safety, and Tumor Control in Two First-In-Human Trials of a Novel Alpha-Emitting Radionuclide for Pancreatic Adenocarcinoma" will be presented on May 2, 2026, at 10:30 am (Central) during the Pancreatic Cancer I: Diagnosis and Treatment session [2] - The presentation will be led by Dr. Harold Jacob, the Principal Investigator, and is based on combined data from two clinical protocols conducted at Hadassah Medical Center in Jerusalem [2] Significance of Presentation - The acceptance of the abstract for oral presentation at DDW is viewed as a milestone for Alpha Tau, indicating growing recognition of the potential of Alpha DaRT to address pancreatic cancer, particularly for patients deemed inoperable at diagnosis [3] - Dr. Jacob emphasized the importance of this presentation as it represents the first clinical data of Alpha DaRT in pancreatic cancer to be shared at a major gastroenterology forum [3]

Core Insights - MAIA Biotechnology, Inc. has reported promising overall survival results for patients treated with ateganosine in its Phase 2 THIO-101 clinical trial for non-small cell lung cancer (NSCLC) [2][4] Company Overview - MAIA Biotechnology is focused on developing targeted immunotherapies for cancer, with its lead program being ateganosine, a first-in-class telomere-targeting agent [8] - The company aims to improve and extend the lives of cancer patients through innovative therapies [8] Clinical Trial Highlights - In the ongoing Phase 2 THIO-101 trial, eight patients have shown overall survival beyond two years without subsequent lines of therapy [2] - The trial has treated a total of 79 patients in Parts A and B, with Part C currently enrolling up to 48 participants in Asia and Europe [2][5] - The treatment regimen of ateganosine followed by cemiplimab has demonstrated an acceptable safety profile in a heavily pre-treated population [2][7] Mechanism of Action - Ateganosine works by targeting telomeres, which are crucial for cancer cell survival and resistance to therapies, leading to selective cancer cell death [4] - The drug induces immune responses that may enhance the effectiveness of subsequent treatments with PD-(L)1 inhibitors [4] Survival Data - One patient in third-line therapy achieved survival of 33 months, while four patients in second-line therapy had survival exceeding 30 months [6] - The expected survival for heavily pre-treated patients is significantly lower, at 5.8 months for standard treatments [6]

Core Viewpoint - T3 Defense Inc. is experiencing a significant increase in business activity and customer engagement, indicating a strengthening pipeline as the company enters an execution phase in the defense sector [1][6]. Business Activity and Demand - The company reported a rise in requests for proposals (RFPs) and inquiries from potential customers across all subsidiaries, reflecting growing demand for integrated defense systems, counter-UAS capabilities, AI-driven security platforms, and advanced engineering services [3][4]. - The increase in engagement is attributed to heightened geopolitical tensions and global investments in defense capabilities, with demand extending beyond OEMs to specialized suppliers and technology providers [2][4]. Subsidiary Performance - T3 Defense's subsidiaries have secured contracts supporting various military applications, showcasing continued strength in defense spending and procurement activity [7]. - Rimon has secured approximately $4.1 million in new multi-year contracts for components related to the Iron Dome missile defense system, highlighting its strategic relevance and technical capabilities [9]. - Tiltan Software Engineering Ltd is experiencing strong demand due to increased adoption of AI and advanced simulation technologies, with interest from both domestic and international customers [8][15]. - Nimbus Drones is witnessing rising demand for advanced drone platforms driven by needs for intelligence, surveillance, and reconnaissance (ISR) capabilities [10]. Market Outlook - The company anticipates further updates as current inquiries are expected to convert into customer engagements and contracts, indicating a positive outlook for sustained growth across its defense technologies [5][6]. - ITS and Positech are also seeing robust demand, with expectations for additional contracts in 2026 as ongoing engagements progress through the procurement cycle [16]. - Zorronet has secured contracts with major Israeli critical infrastructure providers, reflecting a notable increase in inbound customer engagement for integrated situational awareness platforms [16].